Product Overview
[Drug Name]
Generic Name: Ligustrazine Phosphate Capsules
Trade Name: Lotte Ligustrazine Phosphate Capsules 50mg x 24 Capsules
[Main Ingredients]
The active ingredient of this product is ligustrazine phosphate. Chemical Name: 2,3,5,6-Tetramethylpyrazine Phosphate. Molecular Formula: C8H12N2H3PO4H2O. Molecular Weight: 252.21
[Indications/Main Functions]
For ischemic cerebrovascular diseases such as cerebral ischemia, cerebral thrombosis, and cerebral embolism.
[Specifications]
50mg x 24 capsules
[Dosage and Administration]
Oral administration: 50-100 mg (1-2 capsules) three times a day. A course of treatment is one month.
[Adverse Reactions]
Occasionally, stomach discomfort, dry mouth, and drowsiness may occur. Taking after meals can avoid or reduce side effects.
[Contraindications]
This product is contraindicated in patients with cerebral hemorrhage or a predisposition to bleeding.
[Drug Interactions]
Drug interactions may occur if used concomitantly with other medications. Please consult your pharmacist or physician for details.
[Precautions]
Use with caution in patients with cerebral edema or minor bleeding when it is difficult to distinguish between cerebral edema or minor bleeding and ischemic cerebrovascular disease.
[Pediatric Use]
Unclear information available.
[Elderly Use]
Unclear information available.
[Overdose]
Unclear information available.
[Pharmacology and Toxicology]
Ligustrazine phosphate has antiplatelet aggregation, arteriolar dilation, microcirculation improvement, and blood circulation promoting and blood stasis removing effects. It also has a disaggregating effect on aggregated platelets.
